No randomized human trial has established a clinically validated dose all protocols derive from animal data and clinician case series, principally the Sikiric et al
Ethical approval for the validation cohort was obtained from the Institutional Review Board of Chang Gung Memorial Hospital (No: 202201889B0)
At Alkhaleej Clinics we assess every patient first, tailor the dose to you, and treat you in a clean, medically supervised setting
The extent of weight loss varies by productfor example, semaglutide 2.4mg (Wegovy) has shown average weight loss of approximately 15% after 68 weeks in clinical trials, while liraglutide 3mg (Saxenda) typically achieves 5-8% weight loss
It also allows patients to be more aware of what to watch for and when to seek medical help
Outcomes for the first key question were the weight-related indicators [the absolute change and percentage change of body weight, change in BMI and waist circumference, weight loss targets (5%, 10% and 15%) from the baseline to the end of intervention]